ATLANTA, GA – – (Globe Newswire – April 7, 2026) – – A shareholder class action lawsuit has been filed against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts, including allegations that Medpace consistently oversold its projected book-to-bill ratio for fourth quarter 2025 when it knew or recklessly disregarded the impact that cancellations have on the Company’s book-to-bill ratio.

If you purchased Medpace shares between April 22, 2025 and February 9, 2026, and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832, or by visiting the firm’s website at www.holzerlaw.com/case/medpace-holdings/ for more information.

The deadline to ask the court to be appointed lead plaintiff in the case is June 8, 2026.